Novo Nordisk slashes out-of-pocket prices for Wegovy and Ozempic

Novo Nordisk is cutting the out-of-pocket prices of its fashionable weight-loss drugs Wegovy and Ozempic for immoderate consumers.

Current customers who wage for the drugs retired of pouch — without the assistance of wellness security — volition present beryllium charged $349 per month, down from $499, the Danish drugmaker said Monday.

Novo Nordisk besides announced that it volition complaint $199 per period for caller patients who wage for the drugs retired of pocket, with the connection covering 2 months of the treatments. After that, the outgo of the drugs volition emergence to $349 per month. The introductory $199 connection volition beryllium disposable done March 31, 2026, it said.

The caller pricing for radical who wage retired of pouch for the weight-loss drugs comes amid a propulsion from the Trump medication to lower their prices. In a woody announced earlier this month, the medication said radical who trust connected Medicare, Medicaid and the planned "TrumpRx" pharmaceutical website volition get little pricing for Novo Nordisk's GLP-1 drugs, arsenic good arsenic Eli Lilly's Zepbound.

Novo Nordisk wants to marque definite the drugs are "affordable and accessible to those who request them," Dave Moore, enforcement vice president of U.S. operations of Novo Nordisk, said successful the company's Monday statement.

— This is simply a processing communicative and volition beryllium updated.

• Wegovy
• Novo Nordisk
• Ozempic